How Companion Diagnostics Can Support Targeted Drug Launches
September 29, 2026
Coordinated development and practical testing pathways can help ensure eligible patients are identified from the point of approval
5 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
Bruce Levine
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine
View ProfileMusings from The Power List: Claudia Zylberberg
Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale
Latest News
All the latest Medicine Maker articles.
MAPK Inhibitors Restore CAR T-Cell Target in Thyroid Cancer Models
September 24, 2026
Trametinib and dabrafenib increased TSHR expression and improved the activity of CAR T cells in a patient-derived model of anaplastic thyroid cancer
2 min read
Advanced Therapies: Invention or Innovation?
September 23, 2026
Scientific breakthroughs are only true innovations if healthcare systems can deliver them safely, manage their toxicities, and make them accessible at scale
6 min read
“Plug-and-Play” CAR T Platform Enables Post-Infusion Retargeting
September 23, 2026
Meditope-enabled CAR T cells can be tracked, selectively expanded, and directed toward additional tumor antigens using externally administered protein adaptors
2 min read
Musings from The Power List: Michael May
September 22, 2026
CCRM CEO Michael May on quantum computing, commercialization, and the next era of cell therapy
5 min read
The Barriers Limiting Radiopharmaceutical Access
September 21, 2026
From isotope supply to reimbursement, the practical challenges shaping real-world delivery in oncology
5 min read
Long-Term Data Boost MCO-010
September 21, 2026
Four-year RESTORE results will shed new light on the durability of Nanoscope’s mutation-agnostic optogenetic therapy
2 min read
Roving Reporter Asks: How Is Cell and Gene Therapy Manufacturing Becoming More Scalable?
September 18, 2026
IBTV speaks with industry leaders at ASGCT 2026 about the technologies, processes, and manufacturing strategies helping advanced therapies progress toward commercial scale
1 min read
The Power of Policy
September 17, 2026
What one policy change would accelerate progress in drug development and manufacturing? We asked the 2026 Power List.
8 min read
Novartis and BMS Pause Autoimmune CAR T Trials Over Safety Concerns
September 16, 2026
Three deaths linked to immune effector cell-associated hemophagocytic syndrome prompt Novartis to halt eight rap-cel studies
2 min read
Personalized Cancer Vaccine Linked to Three-Year Disease-Free Survival in Head and Neck Cancer
September 16, 2026
All 16 patients who received TG4050 after standard treatment remained disease-free, compared with 13 of 16 patients in the control group
2 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.